Voyageur Pharmaceuticals Ltd.

C$0.12As of Sun 8 Nov 2026, 12:00 UTC
TSXV:VMHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR 2.46%
Div yield —
ROE (111.53%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.37
PE TTM —
TSR TTM (25.00%)
Mkt cap C$27.31M
ROIC (56.70%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.156
29.74%
(17.60%)
Hold 1|7|3|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
27.31%
32.14%
27.85%
23.51%
Revenue$M
1.568
1.632
1.645
1.617
0.42%
7.41%
8.79%
1.91%
Peers (US$19.33M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.366
0.920
0.956
EBIT/Intx
0.880
0.669
0.558
Own earn%
(300.74)
179.23
152.61
Sh yield%
32.95
31.62
29.81
Owners
Insiders/Inst%
6.20
51.67
Short interest%
2.54
SBC / revenue%
1.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
13–22
$1 testx
−0.2
Incr. ROIC%
15